The Influence of Risk and Protective Factors on adolescent alcohol, Cannabis, and Electronic Cigarette Use.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Burrow-Sánchez (2022)
Part one: abuse liability of Vuse Solo (G2) electronic nicotine delivery system relative to combustible cigarettes and nicotine gum.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Campbell (2022)
Influence of electronic cigarette liquid flavors and nicotine concentration on subjective measures of abuse liability in young adult cigarette smokers.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Cobb (2019)
assessing the association Between Electronic Cigarette Use among Cannabis-Naive adolescents and Future Cannabis Use-Overlapping Substances.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Compton (2022)
e-Cigarette and Cigarette Use among Youth: Gateway or Common Liability?
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Delnevo (2023)
E-cigarette use is associated with subsequent cigarette use among young adult non-smokers, over and above a range of antecedent risk factors: a propensity score analysis.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Epstein (2021)
Prospective associations of e-cigarette use with cigarette, alcohol, marijuana, and nonmedical prescription drug use among US adolescents.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Evans-Polce (2020)
human abuse liability assessment of e-cigarettes: Why, what and how?
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Fearon (2022)
Short-Term abstinence Effects in Experienced Electronic Cigarette Users.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Felicione (2019)
associations of Flavored e-Cigarette Uptake With Subsequent Smoking Initiation and Cessation.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Friedman (2020)